The management of high-grade gliomas remains one of the most challenging issues in neurosurgery. High-grade gliomas are the most frequent primary brain tumors in adult patients. Although primary malignant astrocytomas constitute only approximately 2% of all cancers, they are associated with severe disability and high mortality rate. Patients harboring high-grade gliomas are often affected in the most productive years of their lives. In the pediatric population, although high-grade gliomas occur less frequently than in the adults, they are associated with high rates of mobidity and mortality.
